Navigation Links
Zimmer Holdings to Present at Wachovia Healthcare Conference
Date:1/23/2008

WARSAW, Ind., Jan. 23 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH), a leader in the orthopaedics industry, announced today it will be participating in the Wachovia Securities 2008 Healthcare Conference in Boston on January 30, 2008, at 10:15 a.m. Eastern Time.

A live webcast of the presentation can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com. The webcast will be archived for replay following the conference.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer is the worldwide #1 pure-play orthopaedic leader in designing, developing, manufacturing and marketing reconstructive and spinal implants, trauma and related orthopaedic surgical products. Zimmer has operations in more than 24 countries around the world and sells products in more than 100 countries. Zimmer's 2006 sales were approximately $3.5 billion. The Company is supported by the efforts of more than 7,000 employees worldwide.

Visit Zimmer on the worldwide web at http://www.zimmer.com


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements
2. Zimmer Announces Settlement of Federal Investigation
3. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
4. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
5. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
6. H2Diesel Holdings Announces Test Burn Agreement With Mirant Corp.
7. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
8. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
11. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference Today

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...eMarbleEnergyCorp.announcedtodaythatthecompanyandt...lyawarded$2millionbyWashingtonState,sCommunityEcon...nershiptoconstructthestate,sfirstspecialtybiochemi...tmentwillsignificantlyspeedthedevelopmentofourbior...dBlueMarbleEnergyCEOKellyOgilvie."Wearegratefultot...
(Date:11/24/2009)...etforpatientswithadvanced-stage,orrecurrentendomet...rstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ...usedonendocrinetherapyandoncology,todayannouncedpo...ytotoxicpeptideconjugate,AEZS-108(formerlyAN-152),....Inapersonalizedhealthcareapproach,thestudyselecte...
(Date:11/24/2009)...rstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglo...edthatithassubmittedaMAAtotheEuropeanMedicinesAgen...enttherapyindevelopment,forthetreatmentofType1Gauc...elaglucerasealfathathasbeensubmitted,withprevious,...donaglobalsupplyshortageofthecurrentlyapprovedandm...
(Date:11/24/2009)...swire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX ...tiveChairman,willpresentatthe21stAnnualPiperJaffra...er1,2009at10:00a.m.ET. ,, Toaccesstheliveandsub...InvestorRelationssectionofGenomicHealth,swebsiteat...othewebsiteatleast15minutespriortothebeginningofth...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...Inc. (Nasdaq: ARNA ) today announced that Phillip...to its board of directors. Mr. Schneider and Mr.,W...rectors and bring,significant financial and biotec...nce to Arena,s board of directors. Arena,s board a... and Mr. Woods to its Corporate Governance,and Nom...
... Group, LLC of,Birmingham, Alabama, the world,s le...firm, has teamed with RJ Zapata & Associates S.A.,...e management companies in the,Dominican Republic, ...thanol and electricity production facilities in th...int-venture agreement last month to,build faciliti...
...ce announced,today that its vegetable seed busines...on Seed Inc. Based in Salinas, California, Paragon...sales of lettuce varieties. The,company with sales...5.8,million] belongs to the market leaders in the .... market as well as Mexico. With this step Nunhems...
Other Biology Technology:Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors 2Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors 3Masada Teams With Leading Waste Management Firm to Produce Ethanol From Municipal Solid Waste in the Dominican Republic 2Bayer CropScience's Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed 2Bayer CropScience's Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed 3
(Date:11/24/2009)...opening new doors to understanding how sounds asso... a marine mammal or if they hear it at all. , T...ers that NASA uses to detect flaws in the space sh...g scientists to peek inside the giant head of a wh...ional replicas of a whale,s hearing anatomy using ...
(Date:11/24/2009)...eakened and flabby arteries from collapsing have b...stents are no longer needed -- once the arteries a...ly, doctors had no choice but to leave them in pla...ity,s Department of Biomedical Engineering has dev...rries drugs where they,re needed, then dissolves. ...
(Date:11/24/2009)...merican College of Medical Toxicology (ACMT) have ...ion of the Journal of Medical Toxicology (JMT), ...ch 2010. It was previously published by the Unive...Medical Toxicology , an international, peer-review...and practice of medical toxicology. The quarterly...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2A coating for life 2Springer and the American College of Medical Toxicology to work together 2New collaborative center to provide education research on temperate rainforests 9600 1New collaborative center to provide education research on temperate rainforests 9600 2Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 1Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 2Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 3Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 4Hurricane Season Heats Up 54655 1Hurricane Season Heats Up 54655 2Hurricane Season Heats Up 54655 3
...niversity of Minnesota researchers have found a gr... are proven to turn on T-cells, cells that help fi... the May 2006 issue of the journal Immunity, relea...f cells and immune response will help in studying ... the gastrointestinal system," said Stephen McSorl...
...ealthy coral reefs of Madagascar,s northeast coast...er ocean temperatures attributed to global climate...egion. , The survey of a previously unexplored reg...International and its partners documented a much g...e fish species believed new to science and 17 othe...
...n electronic device designed to "zap" away migrain...lief for millions of people who suffer from the de...at the experimental device appears to be effective...ing the onset of the migraine. , The study, led ...ogy investigators, was presented Thursday (6/22) a...
Other Biology News:Healthy coral reefs of Madagascar resisting damage from climate change 2Device effective in zapping the pain out of migraines 2
RNA 6000 Nano Chip Kit from Agilent Technologies
Mouse Anti-Human ALPK3 Monoclonal Antibody, Unconjugated, Clone 4G4 from Abnova Corporation
...Lines ,High Quality, Functionally-Validated, Ion C...or having a critical role in nerve and muscle func... CNS and the heart. Drugs that modulate ion channe...ch as neuropathic pain, cardiac arrhythmia, hypert...
Mouse Anti-Human CD320 Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products: